Laura M. Dember
Renal Section
Department of Medicine
Boston University School of Medicine
Boston
USA
Name/email consistency: high
- Modern treatment of amyloidosis: unresolved questions. Dember, L.M. J. Am. Soc. Nephrol. (2009)
- Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. Dember, L.M., Beck, G.J., Allon, M., Delmez, J.A., Dixon, B.S., Greenberg, A., Himmelfarb, J., Vazquez, M.A., Gassman, J.J., Greene, T., Radeva, M.K., Braden, G.L., Ikizler, T.A., Rocco, M.V., Davidson, I.J., Kaufman, J.S., Meyers, C.M., Kusek, J.W., Feldman, H.I. JAMA (2008)
- Eprodisate for the treatment of renal disease in AA amyloidosis. Dember, L.M., Hawkins, P.N., Hazenberg, B.P., Gorevic, P.D., Merlini, G., Butrimiene, I., Livneh, A., Lesnyak, O., Puéchal, X., Lachmann, H.J., Obici, L., Balshaw, R., Garceau, D., Hauck, W., Skinner, M. N. Engl. J. Med. (2007)
- Anemia in patients with chronic kidney disease: defining the optimal hemoglobin target. Dember, L.M. Nature Clinical Practice. Nephrology (2007)
- Dialysis-related amyloidosis: late finding or hidden epidemic?. Dember, L.M., Jaber, B.L. Semin. Dial (2006)
- Amyloidosis-associated kidney disease. Dember, L.M. J. Am. Soc. Nephrol. (2006)
- Light chains, casts, sheets and fibrils: monoclonal immunoglobulin diseases and immunotactoid/fibrillary glomerulopathy. Dember, L.M. Clinical J. American Society Nephrology : Cjasn (2006)
- Design of the Dialysis Access Consortium (DAC) Clopidogrel Prevention of Early AV Fistula Thrombosis Trial. Dember, L.M., Kaufman, J.S., Beck, G.J., Dixon, B.S., Gassman, J.J., Greene, T., Himmelfarb, J., Hunsicker, L.G., Kusek, J.W., Lawson, J.H., Middleton, J.P., Radeva, M., Schwab, S.J., Whiting, J.F., Feldman, H.I. Clin. Trials (2005)
- Value of static venous pressure for predicting arteriovenous graft thrombosis. Dember, L.M., Holmberg, E.F., Kaufman, J.S. Kidney Int. (2002)
- Critical care issues in the patient with chronic renal failure. Dember, L.M. Crit. Care. Clin (2002)
- Effect of dose-intensive intravenous melphalan and autologous blood stem-cell transplantation on al amyloidosis-associated renal disease. Dember, L.M., Sanchorawala, V., Seldin, D.C., Wright, D.G., LaValley, M., Berk, J.L., Falk, R.H., Skinner, M. Ann. Intern. Med. (2001)